Dow Jones

44 296,51

0,97%

DAX

Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
USOTC
Alseres Pharmaceuticals Inc (CE) (ALSE)
Alseres Pharmaceuticals Inc (CE) (ALSE) Actualités

ALSE

Alseres Pharmaceuticals (CE) (ALSE)

Alseres Pharmaceuticals Inc (CE)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:ALSE

Date	Heure	Source	Titre	Symbole	Société
21/11/2014	22h10	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
18/11/2014	21h09	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
14/08/2014	14h09	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
16/05/2014	15h46	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
10/04/2014	14h52	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
31/03/2014	23h00	Edgar (US Regulatory)	Quarterly Schedule of Portfolio Holdings of Registered Management Investment Company (n-q)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
31/03/2014	23h00	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
28/01/2013	20h40	Edgar (US Regulatory)	Definitive Materials Filed by Investment Companies. (497)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
28/01/2013	20h40	Edgar (US Regulatory)	Annual Report (management Company) (nsar-b)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
28/01/2013	20h37	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
08/01/2013	16h21	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
14/11/2012	12h08	Edgar (US Regulatory)	Quarterly Report (10-Q)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
29/03/2012	22h50	Edgar (US Regulatory)	Annual Report (10-K)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
07/02/2012	22h11	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
27/12/2011	22h44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
27/12/2011	22h00	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (SC 13D/A)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
07/06/2011	22h56	Edgar (US Regulatory)	Statement of Beneficial Ownership (SC 13D)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
03/01/2011	21h46	Edgar (US Regulatory)	Amended tender offer statement by Issuer (SC TO-I/A)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
28/05/2010	22h53	Edgar (US Regulatory)	Confidential Treatment Order (CT ORDER)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
30/04/2010	16h50	Edgar (US Regulatory)	Amended Annual Report (10-K/A)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
10/11/2009	22h44	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (D)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)
17/07/2009	15h31	Edgar (US Regulatory)	(25-NSE)	USOTC:ALSE	Alseres Pharmaceuticals Inc (CE)